Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives
Authors:
- Elif GürsoyEGElif Gürsoy
- Nuray Ulusoy GüzeldemirciNGNuray Ulusoy Güzeldemirci
- 1 March 2007
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 42 (3) , 320-326
Abstract
No abstract availableKeywords
Funding Information
- Istanbul Üniversitesi (T-271/18062003)
This publication has 8 references indexed in Scilit:
- Potential antitumor agents. part 291: synthesis and potential coanthracyclinic activity of Imidazo[2,1-b]thiazole guanylhydrazonesBioorganic & Medicinal Chemistry, 2000
- Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screenDrug Development Research, 1995
- Imidazo[2,1-b]thiazole derivatives. XI. Modulation of the CD2-receptor of human T trypsinized lymphocytes by several imidazo[2,1-b]thiazolesEuropean Journal of Medicinal Chemistry, 1994
- Potential antitumor agents. XX (1) 6-anilinoimidazo[2,1-b]thiazolesPharmaceutica Acta Helvetiae, 1993
- Dérivés de l'imidazo[2,1-b]thiazole X. Propriétés fongistatiques de 2-aminothiazoles et de 6-aryl imidazo[2,1-b]thiazoles substitués respectivement en 4 et en 3 par un reste aryléthyle, aroylméthyle, β-hydroxy β-aryléthyle et éthoxycarbonylméthyleEuropean Journal of Medicinal Chemistry, 1990
- Potential anti-tumor agents XVI. Imidazo[2,1-b]thiazolesEuropean Journal of Medicinal Chemistry, 1988
- Imidazo[2,1-b]thiazoles: analogues du lévamisoleEuropean Journal of Medicinal Chemistry, 1987
- Potential Antitumor Agents, VII. 5‐Substituted 6‐Phenylimidazo[2,1‐b]thiazolesArchiv der Pharmazie, 1982